Literature DB >> 8919741

Seroprevalence of and risk factors for antibodies to herpes simplex viruses, hepatitis B, and hepatitis C among southwestern Hispanic and non-Hispanic white women.

T M Becker1, F Lee, J R Daling, A J Nahmias.   

Abstract

BACKGROUND AND OBJECTIVES: Few published data describe the seroprevalence of antibodies to herpes viruses and hepatitis viruses among Southwestern minority women. GOALS: To determine the prevalence of antibodies to herpes simplex virus type-1 and type-2, hepatitis B, and hepatitis C among 595 southwestern Hispanic and non-Hispanic white patients seeking gynecologic care; and to investigate risk factors associated with seropositivity. STUDY
DESIGN: Analysis of serologic and interview data. Antibody assays were based on purified glycoprotein assays (herpes simplex virus), and commercial assays for hepatitis B virus and hepatitis C virus.
RESULTS: Hispanic ethnicity was a risk factor for herpes simplex virus type-1 (age-adjusted odds ratio, 3.1; 95% confidence interval, 1.8-5.3) but was not associated with antibodies to herpes simplex virus type-2, hepatitis B virus, or hepatitis C virus. Risks associated with seropositivity to herpes simplex virus type-2 included a high lifetime number of sex partners, history of any sexually transmitted disease, and increasing age. Among all patients with herpes simplex virus type-2 antibodies, only 11.1% gave histories of genital herpes infection. For women with antibodies to hepatitis B virus, 31.1% gave histories of hepatitis during adulthood.
CONCLUSIONS: The seroprevalence of antibodies to herpes simplex virus type-1 and herpes simplex virus type-2 was high in this clinic population; the prevalence of antibodies to herpes simplex virus type-1 was significantly higher in Hispanics than in non-Hispanic whites. Antibodies to herpes simplex virus type-2 and hepatitis B virus were associated with most indicator of sexual behavior. The high prevalence of antibodies to herpes simplex virus type-2 and the infrequent reporting of histories of genital herpes suggest that asymptomatic infection with herpes is common among these clinic patients.

Entities:  

Mesh:

Year:  1996        PMID: 8919741     DOI: 10.1097/00007435-199603000-00009

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  7 in total

Review 1.  Genital herpes simplex virus infection in the adolescent: special considerations for management.

Authors:  Lawrence R Stanberry; Susan L Rosenthal
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  HSV type specific antibody tests: patients are ready, are clinicians?

Authors:  R L Ashley; L Corey
Journal:  Genitourin Med       Date:  1997-08

3.  Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.

Authors:  Hideo Nakamura; Hideki Kasuya; John T Mullen; Sam S Yoon; Timothy M Pawlik; Soundararajalu Chandrasekhar; James M Donahue; E Antonio Chiocca; Richard Y Chung; Kenneth K Tanabe
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

4.  Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women.

Authors:  B H van Benthem; J Spaargaren; J A van Den Hoek; J Merks; R A Coutinho; M Prins
Journal:  Sex Transm Infect       Date:  2001-04       Impact factor: 3.519

5.  Incidence of multiple Herpesvirus infection in HIV seropositive patients, a big concern for Eastern Indian scenario.

Authors:  Nilanjan Chakraborty; Sohinee Bhattacharyya; Chandrav De; Anirban Mukherjee; Dwipayan Bhattacharya; Shantanu Santra; Rathindra N Sarkar; Dipanjan Banerjee; Shubhasish K Guha; Utpal K Datta; Sekhar Chakrabarti
Journal:  Virol J       Date:  2010-07-06       Impact factor: 4.099

6.  Regulation of herpes simplex virus 1 replication using tumor-associated promoters.

Authors:  John T Mullen; Hideki Kasuya; Sam S Yoon; Nancy M Carroll; Timothy M Pawlik; Soundararajalu Chandrasekhar; Hideo Nakamura; James M Donahue; Kenneth K Tanabe
Journal:  Ann Surg       Date:  2002-10       Impact factor: 12.969

7.  Seroprevalence of Herpes Simplex Virus Type 1 and 2 in Taiwan and Risk Factor Analysis, 2007.

Authors:  Jen-Hsiang Shen; Kuan-Ying Arthur Huang; Chen Chao-Yu; Chih-Jung Chen; Tzou-Yien Lin; Yhu-Chering Huang
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.